Biomerica Stock Alpha and Beta Analysis
| BMRA Stock | USD 0.32 0.02 5.88% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Biomerica. It also helps investors analyze the systematic and unsystematic risks associated with investing in Biomerica over a specified time horizon. Remember, high Biomerica's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Biomerica's market risk premium analysis include:
Beta 2.1 | Alpha (0.54) | Risk 5.82 | Sharpe Ratio (0.06) | Expected Return (0.33) |
Enterprise Value |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Biomerica |
Biomerica Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Biomerica market risk premium is the additional return an investor will receive from holding Biomerica long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Biomerica. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Biomerica's performance over market.| α | -0.54 | β | 2.10 |
Biomerica expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Biomerica's Buy-and-hold return. Our buy-and-hold chart shows how Biomerica performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.Biomerica Market Price Analysis
Market price analysis indicators help investors to evaluate how Biomerica stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Biomerica shares will generate the highest return on investment. By understating and applying Biomerica stock market price indicators, traders can identify Biomerica position entry and exit signals to maximize returns.
Biomerica Return and Market Media
The median price of Biomerica for the period between Sat, Aug 24, 2024 and Fri, Nov 22, 2024 is 0.34 with a coefficient of variation of 13.18. The daily time series for the period is distributed with a sample standard deviation of 0.05, arithmetic mean of 0.35, and mean deviation of 0.04. The Stock received substential amount of media coverage during this period. Price Growth (%) |
| Timeline |
1 | Why Summit Therapeutics Shares Are Trading Higher By Around 18 Here Are 20 Stocks Moving Premarket - Benzinga | 09/09/2024 |
2 | Biomerica Reports First Quarter Fiscal 2025 Financial Results | 10/16/2024 |
3 | Nasdaq grants Biomerica an additional 180 days to meet listing compliance requirements | 11/07/2024 |
4 | Biomerica Secures Three Key International Patents for inFoods T | 11/21/2024 |
About Biomerica Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Biomerica or other stocks. Alpha measures the amount that position in Biomerica has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2021 | 2022 | 2023 (projected) | Days Sales Outstanding | 14.97 | 49.36 | 63.83 | PTB Ratio | 5.33 | 1.65 | 1.48 |
Biomerica Upcoming Company Events
As portrayed in its financial statements, the presentation of Biomerica's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Biomerica's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Biomerica's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Biomerica. Please utilize our Beneish M Score to check the likelihood of Biomerica's management manipulating its earnings.
| 12th of April 2024 Upcoming Quarterly Report | View | |
| 29th of February 2024 Next Fiscal Quarter End | View |
Build Portfolio with Biomerica
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out Biomerica Backtesting, Biomerica Valuation, Biomerica Correlation, Biomerica Hype Analysis, Biomerica Volatility, Biomerica History and analyze Biomerica Performance. For information on how to trade Biomerica Stock refer to our How to Trade Biomerica Stock guide.You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Biomerica technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.